Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-acting antipsychotics

References

• TandonRNasrallahHAKeshavanMSSchizophrenia, “just the facts” 4. Clinical features and conceptualizationSchizophr Res20091101–312319328655
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders5th edArlington, VAAmerican Psychiatric Association2013
   Google Scholar
• TandonRNasrallahHAKeshavanMSSchizophrenia, “just the facts” 5. Treatment and prevention. Past, present, and futureSchizophr Res20101221–312320655178
   PubMed Web of Science ®Google Scholar
• van OsJKapurSSchizophreniaLancet2009374969063564519700006
   PubMed Web of Science ®Google Scholar
• LehmanAFLiebermanJADixonLBPractice guideline for the treatment of patients with schizophrenia, second edition: work group on schizophrenia [Guidelines]2004 Available from: http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/schizophrenia.pdfAccessed April 7, 2015
   Google Scholar
• ThibautFAcute treatment of schizophrenia: introduction to the Word Federation of Societies of Biological Psychiatry guidelinesPsychiatr Danub201426121124608146
   PubMed Web of Science ®Google Scholar
• van OsJKapurSPsychosis: from diagnosis to syndromeNed Tijdschr Geneeskd2010154A1874 Dutch20456790
   PubMedGoogle Scholar
• HasanAFalkaiPWobrockTWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effectsWorld J Biol Psychiatry201314124423216388
   PubMed Web of Science ®Google Scholar
• HarveyPDVelliganDIBellackASPerformance-based measures of functional skills: usefulness in clinical treatment studiesSchizophr Bull20073351138114817493956
   PubMed Web of Science ®Google Scholar
• Loga-ZecSLogaSAntipsychotics and the quality of life of schizophrenic patientsPsychiatr Danub201022449549721169888
   PubMed Web of Science ®Google Scholar
• The WHOQOL GroupThe World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric propertiesSoc Sci Med19984612156915859672396
   PubMed Web of Science ®Google Scholar
• CellaDFMeasuring quality of life in palliative careSemin Oncol1995222 Suppl 373817537908
   PubMed Web of Science ®Google Scholar
• SchipperHClinchJJOlwenyCLQuality of life studies: definitions and conceptual issuesSpilkerBQuality of Life and Pharmacoeconomics in Clinical TrialsPhiladelphia, PALippincott-Raven19961123
   Google Scholar
• LeidyNKFunctional status and the forward progress of merry-go-rounds: toward a coherent analytical frameworkNurs Res19944341962028047422
   PubMed Web of Science ®Google Scholar
• de AraujoAAde Araujo DantasDdo NascimentoGGQuality of life in patients with schizophrenia: the impact of socio-economic factors and adverse effects of atypical antipsychotics drugsPsychiatr Q201485335736724789610
   PubMed Web of Science ®Google Scholar
• KwonJSChoiJSSocial functioning and quality of life as measures of effectiveness in the treatment of schizophreniaWorld Psychiatry200981353619293958
   PubMed Web of Science ®Google Scholar
• YamauchiKAkiHTomotakeMPredictors of subjective and objective quality of life in outpatients with schizophreniaPsychiatry Clin Neurosci200862440441118778437
   PubMed Web of Science ®Google Scholar
• NaberDVitaATools for measuring clinical effectivenessEur Neuropsychopharmacol200414Suppl 4S435S44415572262
   PubMed Web of Science ®Google Scholar
• FranzMFritzMGallhoferBMeyerTQLiS – development of a schizophrenia-specific quality-of-life scaleHealth Qual Life Outcomes2012106122676639
   PubMed Web of Science ®Google Scholar
• RussoJTrujilloCAWingersonDThe MOS 36-item short form health survey: reliability, validity, and preliminary findings in schizophrenic outpatientsMed Care19983657527569596066
   PubMed Web of Science ®Google Scholar
• MontejoALLaufferJCCuervoJValidation of a specific measure to assess health-related quality of life in patients with schizophrenia and bipolar disorder: the ‘Tolerability and quality of life’ (TOOL) questionnaireAnn Gen Psychiatry201110621396102
   PubMed Web of Science ®Google Scholar
• VothknechtSMeijerCZwindermanAPsychometric evaluation of the Subjective Well-being Under Neuroleptic Treatment Scale (SWN) in patients with schizophrenia, their relatives and controlsPsychiatry Res20132061626723021423
   PubMed Web of Science ®Google Scholar
• RiedelMSpellmannISchennach-WolffRObermeierMMusilRThe RSM-scale: a pilot study on a new specific scale for self- and observer-rated quality of life in patients with schizophreniaQual Life Res201120226327220922485
   PubMed Web of Science ®Google Scholar
• SuCTNgHSYangALLinCYPsychometric evaluation of the Short Form 36 Health Survey (SF-36) and the World Health Organization Quality of Life Scale Brief Version (WHOQOL-BREF) for patients with schizophreniaPsychol Assess201426398098924796341
   PubMed Web of Science ®Google Scholar
• Ascher-SvanumHFariesDEZhuBErnstFRSwartzMSSwansonJWMedication adherence and long-term functional outcomes in the treatment of schizophrenia in usual careJ Clin Psychiatry200667345346016649833
   PubMed Web of Science ®Google Scholar
• HaddadPMBrainCScottJNonadherence with antipsychotic medication in schizophrenia: challenges and management strategiesPatient Relat Outcome Meas20145436225061342
   PubMedGoogle Scholar
• BeraRBPatient outcomes within schizophrenia treatment: a look at the role of long-acting injectable antipsychoticsJ Clin Psychiatry201475Suppl 2303324919169
   PubMed Web of Science ®Google Scholar
• KaplanGCasoyJZummoJImpact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophreniaPatient Prefer Adherence201371171118024265549
   PubMed Web of Science ®Google Scholar
• TakeuchiHSuzukiTUchidaHWatanabeKMimuraMAntipsychotic treatment for schizophrenia in the maintenance phase: a systematic review of the guidelines and algorithmsSchizophr Res20121342–321922522154594
   PubMed Web of Science ®Google Scholar
• KeshavanMSRobertsMWittmannDGuidelines for clinical treatment of early course schizophreniaCurr Psychiatry Rep20068432933416879798
   PubMedGoogle Scholar
• ChughPKRehanHSUnniKESahRKPredictive value of symptoms for quality of life in first-episode schizophreniaNord J Psychiatry201367315315822587635
   PubMed Web of Science ®Google Scholar
• ZouariLThabetJBElloumiZElleuchMZouariNMaalejMQuality of life in patients with schizophrenia: a study of 100 casesEncephale2012382111117 French22516268
   PubMed Web of Science ®Google Scholar
• FujimakiKTakahashiTMorinobuSAssociation of typical versus atypical antipsychotics with symptoms and quality of life in schizophreniaPLoS One201275e3708722615901
   PubMed Web of Science ®Google Scholar
• AwadAGVorugantiLNQuality of life and new antipsychotics in schizophrenia. Are patients better off?Int J Soc Psychiatry199945426827510689610
   PubMed Web of Science ®Google Scholar
• BarkhofEMeijerCJde SonnevilleLMLinszenDHde HaanLInterventions to improve adherence to antipsychotic medication in patients with schizophrenia – a review of the past decadeEur Psychiatry201227191821561742
   PubMed Web of Science ®Google Scholar
• OsborneRHDaltonAHertelJSchroverRSmithDKHealth-related quality of life advantage of long-acting injectable antipsychotic treatment for schizophrenia: a time trade-off studyHealth Qual Life Outcomes2012103522472127
   PubMed Web of Science ®Google Scholar
• BuckleyPFFactors that influence treatment success in schizophreniaJ Clin Psychiatry200869Suppl 3410
   Google Scholar
• CollinsEJHoganTPDesaiHMeasurement of therapeutic response in schizophrenia. A critical surveySchizophr Res1991532492531684722
   PubMed Web of Science ®Google Scholar
• JuckelGMorosiniPLThe new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophreniaCurr Opin Psychiatry200821663063918852573
   PubMed Web of Science ®Google Scholar
• KaneJMImproving patient outcomes in schizophrenia: achieving remission, preventing relapse, and measuring successJ Clin Psychiatry2013749e1824107769
   PubMed Web of Science ®Google Scholar
• KarowAWittmannLSchottleDSchaferILambertMThe assessment of quality of life in clinical practice in patients with schizophreniaDialogues Clin Neurosci201416218519525152657
   PubMed Web of Science ®Google Scholar
• AltamuraACAgugliaEBassiMRethinking the role of long-acting atypical antipsychotics in the community settingInt Clin Psychopharmacol201227633634922859065
   PubMed Web of Science ®Google Scholar
• KaneJMAgugliaEAltamuraACGuidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, ItalyEur Neuropsychopharmacol19988155669452941
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence [NICE]Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. NICE clinical guideline 82Leicester, UKBritish Psychological Society2009
   Google Scholar
• KirschnerMTheodoridouAFusar-PoliPKaiserSJagerMPatients’ and clinicians’ attitude towards long-acting depot antipsychotics in subjects with a first episode of psychosisTher Adv Psychopharmacol201332899924167680
   PubMedGoogle Scholar
• ParelladaEVelliganDIEmsleyRKisslingWLong-acting injectable antipsychotics in first-episode schizophreniaSchizophr Res Treatment2012201231853522966433
   PubMedGoogle Scholar
• LlorcaPMAbbarMCourtetPGuillaumeSLancrenonSSamalinLGuidelines for the use and management of long-acting injectable antipsychotics in serious mental illnessBMC Psychiatry20131334024359031
   PubMed Web of Science ®Google Scholar
• BrissosSVeguillaMRTaylorDBalanza-MartinezVThe role of long-acting injectable antipsychotics in schizophrenia: a critical appraisalTher Adv Psychopharmacol20144519821925360245
   PubMedGoogle Scholar
• TiihonenJHaukkaJTaylorMHaddadPMPatelMXKorhonenPA nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophreniaAm J Psychiatry2011168660360921362741
   PubMed Web of Science ®Google Scholar
• EdlingerMHoferARettenbacherMAFactors influencing the choice of new generation antipsychotic medication in the treatment of patients with schizophreniaSchizophr Res20091132–324625119595578
   PubMed Web of Science ®Google Scholar
• AgidOFoussiasGRemingtonGLong-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse preventionExpert Opin Pharmacother201011142301231720586707
   PubMed Web of Science ®Google Scholar